Evidence map›Paper›PMID 26203188›Full record

ArticleThe Journal of biological chemistry2015

Proteomic and Metabolic Analyses of S49 Lymphoma Cells Reveal Novel Regulation of Mitochondria by cAMP and Protein Kinase A.

Andrea Wilderman, Yurong Guo, Ajit S Divakaruni, Guy Perkins, Lingzhi Zhang, Anne N Murphy, Susan S Taylor, Paul A Insel

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Complex roles of cAMP-PKA-CREB signaling in cancer.Experimental hematology & oncology · 2020
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Mechanisms of cyclic AMP/protein kinase A- and glucocorticoid-mediated apoptosis using S49 lymphoma cells as a model system.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Andrea WildermanFrom the Department of Pharmacology, University of California San Diego, La Jolla, California 92093-0626.
Yurong GuoDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, California 92093-0654.
Ajit S DivakaruniFrom the Department of Pharmacology, University of California San Diego, La Jolla, California 92093-0626.
Guy PerkinsNational Center for Microscopy and Imaging Research, University of California San Diego, La Jolla, California 92093-0608, and.
Lingzhi ZhangFrom the Department of Pharmacology, University of California San Diego, La Jolla, California 92093-0626.
Anne N MurphyFrom the Department of Pharmacology, University of California San Diego, La Jolla, California 92093-0626.
Susan S TaylorFrom the Department of Pharmacology, University of California San Diego, La Jolla, California 92093-0626, Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, California 92093-0654.
Paul A InselFrom the Department of Pharmacology, University of California San Diego, La Jolla, California 92093-0626, Department of Medicine, University of California San Diego, La Jolla, California 92093 pinsel@ucsd.edu.
University of California, San Diego · US

Funding

Project# 4: INTERACTIONS OF ANCHORING PROTEINS WITH THEIR TARGETSP01DK054441 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TAYLOR, SUSAN S. · 1999 to 2017
$27.3M
IVEM and Image Analysis ResourceP41GM103412 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELLISMAN, MARK H · 2012 to 2019
$17.9M
Protection of the Aged MyocardiumR01HL107200 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PATEL, HEMAL H, ROTH, DAVID M · 2011 to 2014
$2.1M
Adrenergic and Purinergic Regulation of Target CellsR01GM066232 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI INSEL, PAUL A · 2004 to 2010
$1.9M
GPCRs: novel targets in cancer-associated fibroblastsR21CA189477 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI INSEL, PAUL A, LOWY, ANDREW M · 2014 to 2015
$371k
Howard Hughes Medical InstituteNCI NIH HHS CA189477NCI NIH HHS R21 CA189477NHLBI NIH HHS HL107200NHLBI NIH HHS R01 HL107200NIDDK NIH HHS DK54441NIDDK NIH HHS P01 DK054441NIGMS NIH HHS GM066232NIGMS NIH HHS P41 GM103412NIGMS NIH HHS R01 GM066232
6 · The paper itself

Abstract

Cyclic AMP (cAMP), acting via protein kinase A (PKA), regulates many cellular responses, but the role of mitochondria in such responses is poorly understood. To define such roles, we used quantitative proteomic analysis of mitochondria-enriched fractions and performed functional and morphologic studies of wild-type (WT) and kin(-) (PKA-null) murine S49 lymphoma cells. Basally, 75 proteins significantly differed in abundance between WT and kin(-) S49 cells. WT, but not kin(-), S49 cells incubated with the cAMP analog 8-(4-chlorophenylthio)adenosine cAMP (CPT-cAMP) for 16 h have (a) increased expression of mitochondria-related genes and proteins, including ones in pathways of branched-chain amino acid and fatty acid metabolism and (b) increased maximal capacity of respiration on branched-chain keto acids and fatty acids. CPT-cAMP also regulates the cellular rate of ATP-utilization, as the rates of both ATP-linked respiration and proton efflux are decreased in WT but not kin(-) cells. CPT-cAMP protected WT S49 cells from glucose or glutamine deprivation, In contrast, CPT-cAMP did not protect kin(-) cells or WT cells treated with the PKA inhibitor H89 from glutamine deprivation. Under basal conditions, the mitochondrial structure of WT and kin(-) S49 cells is similar. Treatment with CPT-cAMP produced apoptotic changes (i.e. decreased mitochondrial density and size and loss of cristae) in WT, but not kin(-) cells. Together, these findings show that cAMP acts via PKA to regulate multiple aspects of mitochondrial function and structure. Mitochondrial perturbation thus likely contributes to cAMP/PKA-mediated cellular responses.

Indexed as

Amino AcidsAnimalsAutophagyCell Line, TumorCyclic AMPCyclic AMP-Dependent Protein KinasesEnergy MetabolismFatty AcidsGene Expression Regulation, NeoplasticImmunoblottingLymphoma, T-CellMetabolic Networks and PathwaysMiceMicroscopy, ElectronMitochondriaMutation8-((4-chlorophenyl)thio)cyclic-3',5'-AMPAmino AcidsCyclic AMPCyclic AMP-Dependent Protein KinasesFatty AcidsThionucleotidescell metabolismcyclic AMP (cAMP)mitochondriaprotein kinase A (PKA)proteomics

Identifiers

PMID26203188
PMCPMC4571978
OpenAlexW1502862198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.